BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7316489)

  • 1. Clinical and biochemical heterogeneity of globoid cell leukodystrophy.
    Farrell DF; Swedberg K
    Ann Neurol; 1981 Oct; 10(4):364-8. PubMed ID: 7316489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form.
    Loonen MC; Van Diggelen OP; Janse HC; Kleijer WJ; Arts WF
    Neuropediatrics; 1985 Aug; 16(3):137-42. PubMed ID: 4047347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases.
    Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y
    J Biol Chem; 1985 Dec; 260(28):14982-7. PubMed ID: 3934152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoelectric focusing of galactosylceramide beta-galactosylceramide beta-galactosidase in cultured skin fibroblasts of patients with Krabbe's globoid-cell leucodystrophy.
    Besley GT
    Biochem Soc Trans; 1975; 3(2):241-4. PubMed ID: 1132549
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of late-life globoid cell leukodystrophy.
    De Gasperi R; Gama Sosa MA; Sartorato E; Battistini S; Raghavan S; Kolodny EH
    Hum Mutat; 1999; 14(3):256-62. PubMed ID: 10477434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd RA
    Vopr Med Khim; 1985; 31(2):128-30. PubMed ID: 2860752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of galactosylceramidase activation by phosphatidylserine.
    Hanada E; Suzuki K
    Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
    Suzuki K
    Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid beta-D-galactosidases in globoid cell leukodystrophy (Krabbe disease).
    Awasthi YC; Lund HW; Lo JT; Srivastava SK
    Birth Defects Orig Artic Ser; 1978; 14(6B):113-26. PubMed ID: 103589
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Nov; 879(2):215-20. PubMed ID: 3094585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
    Wenger DA; Rafi MA; Luzi P
    Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of psychosine upon growth of human skin fibroblasts from patients with globoid cell leukodystrophy.
    Dickerman LH; Kurczynski TW; Macbride RG
    J Neurol Sci; 1981 May; 50(2):181-90. PubMed ID: 7229663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine.
    Kobayashi T; Goto I; Yamanaka T; Suzuki Y; Nakano T; Suzuki K
    Ann Neurol; 1988 Oct; 24(4):517-22. PubMed ID: 3239954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.
    Besley GT; Bain AD
    J Med Genet; 1976 Jun; 13(3):195-9. PubMed ID: 819652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globoid cell leukodystrophy (Krabbe's disease). Metabolic studies with cultured fibroblasts.
    Tanaka H; Suzuki K
    J Neurol Sci; 1978 Oct; 38(3):409-19. PubMed ID: 731265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
    Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
    Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
    Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
    Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.